New hope for stuffy noses: experimental drug targets nasal polyps
NCT ID NCT07420257
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an investigational drug called CM326 in 212 adults with chronic sinusitis and nasal polyps. Participants will receive either CM326 or a placebo for 24 weeks, followed by an open-label period. The goal is to see if the drug shrinks polyps and eases congestion.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shrink nasal polyps and restore smell?
- Triple-Action nasal spray could ease chronic sinusitis
- 3D-Printed nose models could boost sinus rinse results
- Sinus surgery may ease sleep problems in nasal polyp patients
- Real-World check: do new biologics really help severe nasal polyps?
- New study digs into how mepolizumab changes nose bacteria and genes in asthma patients